Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday

• B of A Securities raised the price target for Unity Software Inc. U from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stock from Neutral to Buy. Unity Software shares fell 3% to close at $35.71 on Thursday.
• Truist Securities boosted Vornado Realty Trust VNO price target from $22 to $27. Truist Securities analyst Michael Lewis downgraded the stock from Buy to Hold. Vornado Realty Trust shares gained 2.9% to close at $25.24 on Thursday.
• Needham cut the price target for STAAR Surgical Company STAA from $54 to $52. Needham analyst David Saxon maintained a Buy rating. STAAR Surgical shares fell 1.8% to $42.08 in pre-market trading.
• HC Wainwright & Co. raised the price target for BioLineRx Ltd. BLRX from $19 to $21. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. BioLineRx shares rose 1.1% to $1.78 in pre-market trading.
• Piper Sandler raised Adobe Inc. ADBE price target from $572 to $650. Piper Sandler analyst Brent Bracelin maintained an Overweight rating. Adobe shares fell 1.9% to $541.75 in pre-market trading.
• Piper Sandler raised KeyCorp KEY price target from $ $12 to $13.5. Piper Sandler analyst Scott Siefers upgraded the stock from Neutral to Overweight. KeyCorp shares rose 1.7% to $11.85 in pre-market trading.
• Wells Fargo increased Apellis Pharmaceuticals, Inc. APLS price target from $34 to $64. Wells Fargo analyst Derek Archila upgraded the stock from Equal-Weight to Overweight. Apellis Pharmaceuticals shares gained 3.3% to $44.73 in pre-market trading.
• Redburn Atlantic cut The Estée Lauder Companies Inc. EL price target from $160 to $150. Redburn Atlantic analyst Chris Pitcher upgraded the stock from Sell to Neutral. Estée Lauder shares rose 1.1% to $156.00 in pre-market trading.
• Stifel cut the price target for Lindsay Corporation LNN from $146 to $135. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Lindsay shares rose 2.9% to close at $127.83 on Thursday.
• DA Davidson cut New Relic, Inc. NEWR price target from $95 to $87. DA Davidson analyst Gil Luria downgraded the stock from Buy to Neutral. New Relic shares fell 0.1% to close at $85.40 on Thursday.
• Goldman Sachs boosted MorphoSys AG MOR price target from $3.5 to $9.25. Goldman Sachs analyst Rajan Sharma upgraded the stock from Sell to Neutral. MorphoSys shares rose 1.4% to $8.07 in pre-market trading.

Check This Out: Stitch Fix Likely To Narrower Q4 Loss; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts